The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status
Smoking is an important contributor to cardiovascular disease (CVD) risk and is highly prevalent in the HIV population. We have shown that rosuvastatin improves markers of inflammation (soluble tumor necrosis factor alpha receptor-II, interferon γ inducible protein 10 and lipoprotein associated phospholipase A2), immune activation [soluble CD14, proportion of tissue factor positive patrolling (CD14dimCD16+) monocytes…